HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at HC Wainwright. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by HC Wainwright.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
VERU Veru	$0.41 -6.8%	2/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$2.00	Low	View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 2/8/2024
ARWR Arrowhead Pharmaceuticals	$30.85 -2.5%	2/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$90.00	Low	View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/8/2024
OESX Orion Energy Systems	$1.07 -10.1%	2/8/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$7.00 -> $3.00	Low	View details for HC Wainwright rating of Orion Energy Systems (NASDAQ:OESX) on 2/8/2024
RLYB Rallybio	$1.71 +1.2%	2/7/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$17.00 -> $12.00	Low	View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 2/7/2024
ITRM Iterum Therapeutics	$1.59 -3.6%	2/7/2024	Upgraded by	HC Wainwright	Analyst E. Arce	Neutral -> Buy	$6.00	Low	View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 2/7/2024
HUT Hut 8	C$10.05 +10.3%	2/6/2024	Reiterated by	HC Wainwright	Analyst M. Colonnese	Sell		N/A	View details for HC Wainwright rating of Hut 8 (TSE:HUT) on 2/6/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CLSK CleanSpark	$10.50 +12.8%	2/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$14.00	Low	View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 2/6/2024
EFTR eFFECTOR Therapeutics	$10.51 +5.6%	2/6/2024	Target Raised by	HC Wainwright	Analyst R. Burns	Buy -> Buy	$24.00	Low	View details for HC Wainwright rating of eFFECTOR Therapeutics (NASDAQ:EFTR) on 2/6/2024
HUT Hut 8	$7.47 +10.3%	2/6/2024	Downgraded by	HC Wainwright	Analyst M. Colonnese	Neutral -> Sell	$5.50	Low	View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 2/6/2024
SGMO Sangamo Therapeutics	$0.55 +14.6%	2/6/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 2/6/2024
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	2/6/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$397.00 -> $457.00	Low	View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/6/2024
PLRX Pliant Therapeutics	$16.29 +2.0%	2/5/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$52.00 -> $48.00	Low	View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 2/5/2024
ACET Adicet Bio	$3.38 +5.3%	2/2/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$26.00 -> $10.00	Low	View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 2/2/2024
TRNS Transcat	$110.91 +2.1%	1/31/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$108.00 -> $124.00	Low	View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 1/31/2024
CALC CalciMedica	$5.11 -10.0%	1/29/2024	Reiterated by	HC Wainwright	Analyst J. Pantginis	Buy	$20.00	Low	View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 1/29/2024
ONCT Oncternal Therapeutics	$9.55 -0.5%	1/29/2024	Target Raised by	HC Wainwright	Analyst R. Selvaraju	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Oncternal Therapeutics (NASDAQ:ONCT) on 1/29/2024
BBIO BridgeBio Pharma	$32.96 -2.4%	1/29/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$22.00 -> $47.00	Low	View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 1/29/2024
GMAB Genmab A/S	$27.79 -0.6%	1/29/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$49.00 -> $50.00	Low	View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 1/29/2024
IFRX InflaRx	$1.58 +0.6%	1/25/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$9.00 -> $8.00	Low	View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 1/25/2024
BTCS BTCS	$1.64 +5.1%	1/25/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of BTCS (NASDAQ:BTCS) on 1/25/2024
USAS Americas Silver	$0.22	1/24/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$1.50 -> $0.80	N/A	View details for HC Wainwright rating of Americas Silver (NYSEAMERICAN:USAS) on 1/24/2024
OCGN Ocugen	$0.52 -1.9%	1/24/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$5.00 -> $7.00	Low	View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 1/24/2024
BNTX BioNTech	$94.10 -1.0%	1/23/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$133.00 -> $107.00	Low	View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 1/23/2024
VIR Vir Biotechnology	$9.23 +1.9%	1/23/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$95.00 -> $85.00	Low	View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 1/23/2024
TLPH Talphera	$0.86 -1.1%	1/22/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$5.00 -> $6.00	Low	View details for HC Wainwright rating of Talphera (NASDAQ:TLPH) on 1/22/2024
EKSO Ekso Bionics	$2.02 -3.3%	1/22/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$9.00 -> $10.00	Low	View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 1/22/2024
TIL Instil Bio	$11.66 +1.2%	1/22/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$18.00	N/A	View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 1/22/2024
VRNA Verona Pharma	$16.28 -0.4%	1/22/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 1/22/2024
ACRS Aclaris Therapeutics	$1.18 +11.3%	1/22/2024	Downgraded by	HC Wainwright	Analyst R. Selvaraju	Buy -> Neutral		Low	View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/22/2024
AG First Majestic Silver	$4.65 -0.4%	1/19/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$12.00 -> $6.75	Low	View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 1/19/2024
SDIG Stronghold Digital Mining	$5.30 +15.0%	1/19/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Stronghold Digital Mining (NASDAQ:SDIG) on 1/19/2024
KRRO Korro Bio	$58.72 -1.4%	1/19/2024	Reiterated by	HC Wainwright	Analyst M. Kapoor	Buy -> Buy	$100.00	Low	View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 1/19/2024
ALLO Allogene Therapeutics	$4.37 +5.3%	1/19/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$12.00 -> $10.00	Low	View details for HC Wainwright rating of Allogene Therapeutics (NASDAQ:ALLO) on 1/19/2024
SGMO Sangamo Therapeutics	$0.55 +14.6%	1/19/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 1/19/2024
ONCY Oncolytics Biotech	$1.02 +14.6%	1/19/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 1/19/2024
QURE uniQure	$5.47 -2.5%	1/19/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 1/19/2024
IKNA Ikena Oncology	$1.40	1/19/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Ikena Oncology (NASDAQ:IKNA) on 1/19/2024
UEC Uranium Energy	$7.60 -3.6%	1/18/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$8.25 -> $9.75	N/A	View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 1/18/2024
SLN Silence Therapeutics	$21.20 +0.8%	1/18/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$75.00	Low	View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 1/18/2024
IVVD Invivyd	$5.04 +6.8%	1/18/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$5.00 -> $15.00	Low	View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 1/18/2024

HALO Halozyme Therapeutics	$35.24 -0.2%	1/18/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$61.00 -> $48.00	Low	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 1/18/2024
KA Kineta	$2.42 -3.6%	1/18/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$8.00	Low	View details for HC Wainwright rating of Kineta (NASDAQ:KA) on 1/18/2024
EOLS Evolus	$13.36 +1.6%	1/17/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$27.00	Low	View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 1/17/2024
APLS Apellis Pharmaceuticals	$68.12 +2.1%	1/17/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$82.00 -> $92.00	Low	View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 1/17/2024
NGNE Neurogene	$29.79 -2.1%	1/17/2024	Reiterated by	HC Wainwright	Analyst M. Kapoor	Buy -> Buy	$45.00	Low	View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 1/17/2024
ASPN Aspen Aerogels	$11.84 +4.3%	1/16/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$30.00 -> $20.00	Low	View details for HC Wainwright rating of Aspen Aerogels (NYSE:ASPN) on 1/16/2024
NKTX Nkarta	$10.96 +7.9%	1/16/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$10.00 -> $22.00	Low	View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 1/16/2024
EYPT EyePoint Pharmaceuticals	$29.12 -0.9%	1/16/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$35.00 -> $33.00	Low	View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 1/16/2024
SANA Sana Biotechnology	$6.16 +1.0%	1/16/2024	Upgraded by	HC Wainwright	Analyst E. Bodnar	Neutral -> Buy	$12.00	Low	View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 1/16/2024
VCEL Vericel	$45.85 +3.7%	1/16/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$44.50 -> $46.00	Low	View details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 1/16/2024
MDWD MediWound	$12.14 -0.2%	1/16/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$26.00 -> $28.00	Low	View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 1/16/2024
EXK Endeavour Silver	$1.56 -1.3%	1/11/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$7.25 -> $6.00	Low	View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 1/11/2024
TGTX TG Therapeutics	$14.64 +1.9%	1/11/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$41.00 -> $45.00	Low	View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 1/11/2024
LFMD LifeMD	$5.79 +1.4%	1/11/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$10.00 -> $12.00	Low	View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 1/11/2024
TERN Terns Pharmaceuticals	$6.27 +9.8%	1/10/2024	Target Lowered by	HC Wainwright	-	Neutral -> Neutral	$8.00 -> $5.50	Low	View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 1/10/2024
FF First Mining Gold	C$0.12	1/9/2024	Target Lowered by	HC Wainwright	-		C$0.80 -> C$0.70	N/A	View details for HC Wainwright rating of First Mining Gold (TSE:FF) on 1/9/2024
VZLA Vizsla Silver	$1.40 +0.7%	1/9/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$2.50 -> $3.25	Low	View details for HC Wainwright rating of Vizsla Silver (NYSE:VZLA) on 1/9/2024
ADMA ADMA Biologics	$5.17 -0.2%	1/9/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$5.00 -> $6.00	Low	View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 1/9/2024
PRTG Portage Biotech	$0.64 -3.0%	1/8/2024	Downgraded by	HC Wainwright	Analyst R. Burns	Buy -> Neutral		Low	View details for HC Wainwright rating of Portage Biotech (NASDAQ:PRTG) on 1/8/2024
HARP Harpoon Therapeutics	$22.34 +0.0%	1/8/2024	Downgraded by	HC Wainwright	Analyst S. Ramakanth	Buy -> Neutral	$12.00 -> $23.00	Low	View details for HC Wainwright rating of Harpoon Therapeutics (NASDAQ:HARP) on 1/8/2024
ASND Ascendant Resources	C$0.07	1/8/2024	Target Raised by	HC Wainwright	-		C$0.25 -> C$0.30	N/A	View details for HC Wainwright rating of Ascendant Resources (TSE:ASND) on 1/8/2024
ABSI Absci	$4.11 +3.5%	1/8/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.00 -> $7.00	Low	View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 1/8/2024
SABS SAB Biotherapeutics	$5.43 -2.0%	1/8/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$1.00 -> $10.00	Low	View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 1/8/2024
GOSS Gossamer Bio	$0.86 -1.1%	1/8/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$5.00 -> $10.00	Low	View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 1/8/2024
LBPH Longboard Pharmaceuticals	$19.32 -6.1%	1/8/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$25.00 -> $60.00	Low	View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 1/8/2024
ANGO AngioDynamics	$6.15 +1.2%	1/8/2024	Target Lowered by	HC Wainwright	Analyst Y. Chen	Buy -> Buy	$20.00 -> $18.00	Low	View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 1/8/2024
OKYO OKYO Pharma	$1.43	1/8/2024	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.00 -> $5.00	Low	View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 1/8/2024
NGNE Neurogene	$29.79 -2.1%	1/8/2024	Initiated by	HC Wainwright	Analyst M. Kapoor	Buy	$45.00	Low	View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 1/8/2024
BNXA Banxa	C$0.61 -1.6%	1/5/2024	Target Lowered by	HC Wainwright	-		C$4.00 -> C$1.00	N/A	View details for HC Wainwright rating of Banxa (CVE:BNXA) on 1/5/2024
VIRX Viracta Therapeutics	$0.56	1/5/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$10.00 -> $4.00	Low	View details for HC Wainwright rating of Viracta Therapeutics (NASDAQ:VIRX) on 1/5/2024
ONCY Oncolytics Biotech	$1.02 +14.6%	1/4/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 1/4/2024
RIGL Rigel Pharmaceuticals	$1.14 +1.8%	1/4/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 1/4/2024
LSTA Lisata Therapeutics	$2.61 -1.5%	1/4/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 1/4/2024
MNKD MannKind	$3.43	1/4/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.50	Low	View details for HC Wainwright rating of MannKind (NASDAQ:MNKD) on 1/4/2024
COCP Cocrystal Pharma	$1.50 -1.3%	1/3/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$12.00 -> $10.00	Low	View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 1/3/2024
AVXL Anavex Life Sciences	$5.69 +1.8%	1/3/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$54.00 -> $40.00	Low	View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/3/2024
CORT Corcept Therapeutics	$22.49 +1.0%	1/2/2024	Target Lowered by	HC Wainwright	-	Buy -> Buy	$34.00 -> $28.00	Low	View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 1/2/2024
SNDX Syndax Pharmaceuticals	$22.00 -1.3%	1/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$41.00	Low	View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 1/2/2024
BIOR Biora Therapeutics	$0.84 -2.3%	1/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy		Low	View details for HC Wainwright rating of Biora Therapeutics (NASDAQ:BIOR) on 1/2/2024
ATAI Atai Life Sciences	$1.75 +2.9%	1/2/2024	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	N/A	View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 1/2/2024
CTSO Cytosorbents	$1.02	12/29/2023	Downgraded by	HC Wainwright	Analyst S. Lee	Buy -> Neutral	$5.50 -> $1.00	Low	View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 12/29/2023
ACRS Aclaris Therapeutics	$1.18 +11.3%	12/29/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 12/29/2023
VRNA Verona Pharma	$16.28 -0.4%	12/29/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 12/29/2023
CODX Co-Diagnostics	$1.20 +1.7%	12/29/2023	Reiterated by	HC Wainwright	-	Neutral -> Neutral	$3.00	Low	View details for HC Wainwright rating of Co-Diagnostics (NASDAQ:CODX) on 12/29/2023
BCTX BriaCell Therapeutics	$3.92 -0.5%	12/28/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	Low	View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 12/28/2023
ANY Sphere 3D	$2.38 +10.7%	12/28/2023	Reiterated by	HC Wainwright	Analyst K. Dede	Buy	$5.00	Low	View details for HC Wainwright rating of Sphere 3D (NASDAQ:ANY) on 12/28/2023
ZVRA Zevra Therapeutics	$5.95 +2.4%	12/28/2023	Reiterated by	HC Wainwright	Analyst O. Livnat	Buy -> Buy	$10.00 -> $15.00	Low	View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 12/28/2023
VERA Vera Therapeutics	$37.56 +0.1%	12/27/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Vera Therapeutics (NASDAQ:VERA) on 12/27/2023
CYTK Cytokinetics	$78.94 +2.4%	12/27/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$58.00 -> $94.00	Low	View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 12/27/2023
BLTE Belite Bio	$45.87 +0.8%	12/27/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$59.00	Low	View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 12/27/2023

IOVA Iovance Biotherapeutics	$8.68 +7.6%	12/27/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$38.00 -> $28.00	Low	View details for HC Wainwright rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 12/27/2023
CHRS Coherus BioSciences	$2.38 +2.6%	12/27/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$13.00	Low	View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 12/27/2023
ONCT Oncternal Therapeutics	$9.55 -0.5%	12/27/2023	Reiterated by	HC Wainwright	Analyst R. Selvaraju	Buy -> Buy	$40.00	Low	View details for HC Wainwright rating of Oncternal Therapeutics (NASDAQ:ONCT) on 12/27/2023
GRCL Gracell Biotechnologies	$10.23	12/26/2023	Downgraded by	HC Wainwright	Analyst E. Bodnar	Buy -> Neutral	$13.00 -> $10.00	Low	View details for HC Wainwright rating of Gracell Biotechnologies (NASDAQ:GRCL) on 12/26/2023
KRTX Karuna Therapeutics	$316.12 +0.7%	12/26/2023	Downgraded by	HC Wainwright	Analyst R. Selvaraju	Buy -> Neutral	$300.00 -> $330.00	Low	View details for HC Wainwright rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/26/2023
RVPH Reviva Pharmaceuticals	$4.33 +3.6%	12/26/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 12/26/2023
TYRA Tyra Biosciences	$18.26 +1.4%	12/26/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$19.00	Low	View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 12/26/2023
AXSM Axsome Therapeutics	$95.68 +1.8%	12/26/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$180.00	Low	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/26/2023
EQ Equillium	$1.52 +2.7%	12/26/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$4.50 -> $4.00	Low	View details for HC Wainwright rating of Equillium (NASDAQ:EQ) on 12/26/2023
SNDX Syndax Pharmaceuticals	$22.00 -1.3%	12/22/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$42.00 -> $41.00	Low	View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 12/22/2023
GAU Galiano Gold	$0.89	12/22/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$2.20	N/A	View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 12/22/2023
ALPN Alpine Immune Sciences	$28.41 +4.8%	12/22/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$17.00 -> $32.00	Low	View details for HC Wainwright rating of Alpine Immune Sciences (NASDAQ:ALPN) on 12/22/2023
LEGN Legend Biotech	$58.72 +0.2%	12/22/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$87.00	Low	View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 12/22/2023
XOMA XOMA	$20.04 -1.4%	12/22/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$74.00	Low	View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 12/22/2023
BHVN Biohaven	$46.92 -0.7%	12/22/2023	Initiated by	HC Wainwright	Analyst D. Tsao	Buy	$50.00	Low	View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 12/22/2023
FURY Fury Gold Mines	C$0.48 -5.9%	12/21/2023	Target Raised by	HC Wainwright	-	Buy	C$1.40 -> C$1.50	N/A	View details for HC Wainwright rating of Fury Gold Mines (TSE:FURY) on 12/21/2023
CLNN Clene	$0.42 -4.6%	12/21/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$7.00	Low	View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 12/21/2023
FURY Fury Gold Mines	$0.35 -5.4%	12/21/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$1.40 -> $1.50	N/A	View details for HC Wainwright rating of Fury Gold Mines (NYSEAMERICAN:FURY) on 12/21/2023
IVA Inventiva	$3.59	12/21/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$36.00 -> $24.00	Low	View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 12/21/2023
IMVT Immunovant	$35.27 +0.1%	12/21/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$47.00 -> $51.00	Low	View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 12/21/2023
ARGX argenx	$394.89 +0.8%	12/21/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$582.00 -> $451.00	Low	View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 12/21/2023
ETNB 89bio	$8.45 +1.3%	12/20/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$35.00 -> $32.00	Low	View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 12/20/2023
MARA Marathon Digital	$21.58 +23.0%	12/20/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$20.00 -> $24.00	Low	View details for HC Wainwright rating of Marathon Digital (NASDAQ:MARA) on 12/20/2023
REE REE Automotive	$6.12 +1.5%	12/19/2023	Reiterated by	HC Wainwright	Analyst A. Dayal	Buy	$15.00	Low	View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 12/19/2023
KRON Kronos Bio	$1.07 +1.9%	12/19/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$9.00 -> $2.50	Low	View details for HC Wainwright rating of Kronos Bio (NASDAQ:KRON) on 12/19/2023
RICK RCI Hospitality	$60.78 +1.5%	12/19/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$115.00	Low	View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 12/19/2023
CARA Cara Therapeutics	$0.52 -1.9%	12/19/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$7.00 -> $2.50	Low	View details for HC Wainwright rating of Cara Therapeutics (NASDAQ:CARA) on 12/19/2023
CKPT Checkpoint Therapeutics	$1.99 +3.1%	12/19/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$34.00	Low	View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 12/19/2023
UNCY Unicycive Therapeutics	$1.14 -0.9%	12/19/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.50	Low	View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 12/19/2023
CRNX Crinetics Pharmaceuticals	$38.46 +1.8%	12/19/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$42.00	Low	View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 12/19/2023
VRDN Viridian Therapeutics	$17.96 +1.2%	12/18/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$37.00	Low	View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/18/2023
MIRM Mirum Pharmaceuticals	$27.02 +1.0%	12/18/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$60.00 -> $58.00	Low	View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 12/18/2023
ITRG Integra Resources	$0.81 -4.7%	12/18/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.00	N/A	View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 12/18/2023
ALNY Alnylam Pharmaceuticals	$169.50 +0.5%	12/15/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$395.00	Low	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/15/2023
TVTX Travere Therapeutics	$8.30 +0.2%	12/15/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$18.00 -> $20.00	Low	View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 12/15/2023
CBAY CymaBay Therapeutics	$24.96 +4.0%	12/15/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$24.00 -> $28.00	Low	View details for HC Wainwright rating of CymaBay Therapeutics (NASDAQ:CBAY) on 12/15/2023
MYO Myomo	$3.62 -1.1%	12/15/2023	Initiated by	HC Wainwright	Analyst S. Lee	Buy	$6.50	N/A	View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 12/15/2023
COGT Cogent Biosciences	$6.38 +7.2%	12/15/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$27.00 -> $13.00	Low	View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 12/15/2023
ACXP Acurx Pharmaceuticals	$3.07	12/15/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$13.00 -> $14.00	Low	View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 12/15/2023
AADI Aadi Bioscience	$1.77 +1.1%	12/15/2023	Downgraded by	HC Wainwright	Analyst R. Burns	Buy -> Neutral		Low	View details for HC Wainwright rating of Aadi Bioscience (NASDAQ:AADI) on 12/15/2023
RPHM Reneo Pharmaceuticals	$1.65 +0.6%	12/15/2023	Downgraded by	HC Wainwright	Analyst M. Kapoor	Buy -> Neutral		Low	View details for HC Wainwright rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 12/15/2023
MBRX Moleculin Biotech	$0.49 -5.7%	12/14/2023	Reiterated by	HC Wainwright	Analyst V. Bernardino	Buy	$3.00	Low	View details for HC Wainwright rating of Moleculin Biotech (NASDAQ:MBRX) on 12/14/2023
DRD DRDGOLD	$7.55 -2.7%	12/13/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$17.00 -> $13.25	Low	View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 12/13/2023
HARP Harpoon Therapeutics	$22.34 +0.0%	12/13/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$7.50 -> $12.00	Low	View details for HC Wainwright rating of Harpoon Therapeutics (NASDAQ:HARP) on 12/13/2023
ORIC ORIC Pharmaceuticals	$12.25 -2.9%	12/13/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$16.00 -> $15.00	Low	View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 12/13/2023
HLVX HilleVax	$15.06 +0.6%	12/13/2023	Initiated by	HC Wainwright	Analyst M. Caufield	Buy	$28.00	Low	View details for HC Wainwright rating of HilleVax (NASDAQ:HLVX) on 12/13/2023
AXSM Axsome Therapeutics	$95.68 +1.8%	12/12/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$180.00	Low	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/12/2023
SOUN SoundHound AI	$1.95 +14.0%	12/11/2023	Reiterated by	HC Wainwright	Analyst S. Buck	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 12/11/2023
HUMA Humacyte	$3.14 +7.5%	12/11/2023	Initiated by	HC Wainwright	Analyst V. Bernardino	Buy	$6.00	Low	View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 12/11/2023
PSTX Poseida Therapeutics	$3.38 +1.5%	12/11/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$15.00 -> $20.00	Low	View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 12/11/2023

RLAY Relay Therapeutics	$8.89 +1.7%	12/11/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$19.00 -> $17.00	Low	View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 12/11/2023
BPMC Blueprint Medicines	$74.16 -0.1%	12/11/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$85.00	Low	View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 12/11/2023
ENTX Entera Bio	$0.84 +13.5%	12/11/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 12/11/2023
ETON Eton Pharmaceuticals	$4.41 -3.7%	12/11/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 12/11/2023
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	12/11/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$390.00 -> $397.00	Low	View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/11/2023
GNFT Genfit	$3.70 +3.9%	12/8/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 12/8/2023
RIGL Rigel Pharmaceuticals	$1.14 +1.8%	12/8/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/8/2023
KURA Kura Oncology	$20.33 -0.1%	12/8/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$32.00	Low	View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 12/8/2023
UROY Uranium Royalty	$2.99 -4.5%	12/8/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$6.20 -> $6.40	Low	View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 12/8/2023
QSI Quantum-Si	$1.44 +0.7%	12/8/2023	Initiated by	HC Wainwright	Analyst S. Ramakanth	Buy	$3.00	Low	View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 12/8/2023
SLDB Solid Biosciences	$7.24 -0.1%	12/8/2023	Initiated by	HC Wainwright	Analyst A. He	Buy	$9.00	Low	View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 12/8/2023
CELC Celcuity	$14.47 -1.0%	12/8/2023	Initiated by	HC Wainwright	Analyst S. Ramakanth	Buy	$27.00	Low	View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 12/8/2023
CERE Cerevel Therapeutics	$42.18 +1.6%	12/7/2023	Downgraded by	HC Wainwright	Analyst D. Tsao	Buy -> Neutral	$41.00 -> $45.00	Low	View details for HC Wainwright rating of Cerevel Therapeutics (NASDAQ:CERE) on 12/7/2023
IGMS IGM Biosciences	$12.95 +17.9%	12/7/2023	Downgraded by	HC Wainwright	Analyst R. Burns	Buy -> Neutral	$11.00 -> $7.00	Low	View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 12/7/2023
CHRS Coherus BioSciences	$2.38 +2.6%	12/7/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$13.00	Low	View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 12/7/2023
ANIX Anixa Biosciences	$4.48 +0.4%	12/7/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 12/7/2023
USGO U.S. GoldMining	$6.00 -0.5%	12/7/2023	Target Raised by	HC Wainwright	Analyst H. Ihle	Buy -> Buy	$22.00 -> $23.00	Low	View details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 12/7/2023
IPSC Century Therapeutics	$4.45 -2.4%	12/7/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$13.00	Low	View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 12/7/2023
CDTX Cidara Therapeutics	$0.67 +3.1%	12/7/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 12/7/2023
LUMO Lumos Pharma	$3.03 -0.7%	12/7/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$28.00	Low	View details for HC Wainwright rating of Lumos Pharma (NASDAQ:LUMO) on 12/7/2023
TRML Tourmaline Bio	$36.24 +2.9%	12/4/2023	Reiterated by	HC Wainwright	Analyst Y. Chen	Buy		Low	View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 12/4/2023
EYPT EyePoint Pharmaceuticals	$29.12 -0.9%	12/5/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$25.00 -> $35.00	Low	View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 12/5/2023
ETNB 89bio	$8.45 +1.3%	12/5/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$35.00	Low	View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 12/5/2023
TVTX Travere Therapeutics	$8.30 +0.2%	12/5/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$18.00	Low	View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 12/5/2023
PRAX Praxis Precision Medicines	$45.04 +2.1%	12/5/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$105.00	Low	View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 12/5/2023
RIOT Riot Platforms	$13.05 +15.3%	12/5/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$18.00 -> $20.00	N/A	View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 12/5/2023
MRNS Marinus Pharmaceuticals	$9.99 +0.8%	12/5/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$27.00	Low	View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 12/5/2023
OKYO OKYO Pharma	$1.43	12/5/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.00	Low	View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 12/5/2023
NR Newpark Resources	$6.17 +1.8%	12/5/2023	Initiated by	HC Wainwright	Analyst A. Dayal	Buy	$12.00	Low	View details for HC Wainwright rating of Newpark Resources (NYSE:NR) on 12/5/2023
ASPI ASP Isotopes	$3.04 -1.6%	12/5/2023	Initiated by	HC Wainwright	Analyst H. Ihle	Buy	$3.25	Low	View details for HC Wainwright rating of ASP Isotopes (NASDAQ:ASPI) on 12/5/2023
VALN Valneva	$8.14 -1.9%	12/4/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$26.00	Low	View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 12/4/2023
BTBT Bit Digital	$2.74 +12.8%	12/4/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$4.00 -> $5.00	Low	View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 12/4/2023
SNSE Sensei Biotherapeutics	$0.81 -4.7%	12/4/2023	Reiterated by	HC Wainwright	Analyst E. White	Buy	$4.00	Low	View details for HC Wainwright rating of Sensei Biotherapeutics (NASDAQ:SNSE) on 12/4/2023
LGVN Longeveron	$0.52 -1.9%	12/4/2023	Reiterated by	HC Wainwright	Analyst B. Pachaiyappan	Buy	$6.00	Low	View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 12/4/2023
GANX Gain Therapeutics	$4.84 +1.9%	12/4/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$10.00 -> $9.00	Low	View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 12/4/2023
KRRO Korro Bio	$58.72 -1.4%	12/4/2023	Initiated by	HC Wainwright	Analyst M. Kapoor	Buy	$100.00	Low	View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 12/4/2023
SCLX Scilex	$1.63 +1.2%	12/4/2023	Reiterated by	HC Wainwright	Analyst R. Selvaraju	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Scilex (NASDAQ:SCLX) on 12/4/2023
KZR Kezar Life Sciences	$0.95 +2.2%	12/4/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 12/4/2023
COCP Cocrystal Pharma	$1.50 -1.3%	12/4/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$12.00	Low	View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 12/4/2023
ALT Altimmune	$9.69 -6.4%	12/1/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 12/1/2023
NEXCF Nextech3D.AI	$0.14 +7.7%	11/30/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$1.00 -> $0.50	Low	View details for HC Wainwright rating of Nextech3D.AI (OTCMKTS:NEXCF) on 11/30/2023
IMGN ImmunoGen	$31.23 +5.7%	11/30/2023	Downgraded by	HC Wainwright	Analyst S. Ramakanth	Buy -> Neutral	$28.00 -> $31.26	N/A	View details for HC Wainwright rating of ImmunoGen (NASDAQ:IMGN) on 11/30/2023
CLGN CollPlant Biotechnologies	$5.60 -1.4%	11/30/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/30/2023
PYXS Pyxis Oncology	$3.71 -1.6%	11/30/2023	Reiterated by	HC Wainwright	Analyst S. Ramakanth	Buy	$4.00	Low	View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 11/30/2023
PRTG Portage Biotech	$0.64 -3.0%	11/29/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$9.00 -> $6.00	Low	View details for HC Wainwright rating of Portage Biotech (NASDAQ:PRTG) on 11/29/2023
CAN Canaan	$1.54 +20.3%	11/29/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$4.00 -> $3.00	Low	View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 11/29/2023
BITF Bitfarms	$2.52 +10.5%	11/29/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$3.00 -> $4.00	Low	View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 11/29/2023
RICK RCI Hospitality	$60.78 +1.5%	11/29/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$115.00	Low	View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 11/29/2023
CABA Cabaletta Bio	$25.38 +7.6%	11/29/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 11/29/2023
CARM Carisma Therapeutics	$2.10 +4.5%	11/29/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 11/29/2023

ICCM IceCure Medical	$1.43 +3.6%	11/29/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$3.00	Low	View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 11/29/2023
ARGX argenx	$394.89 +0.8%	11/29/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$595.00 -> $582.00	Low	View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 11/29/2023
EDSA Edesa Biotech	$4.76 -3.6%	11/29/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$70.00 -> $21.00	Low	View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 11/29/2023
RLYB Rallybio	$1.71 +1.2%	11/29/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$17.00	Low	View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 11/29/2023
ERAS Erasca	$1.76 +3.5%	11/28/2023	Target Lowered by	HC Wainwright	Analyst A. Maldonado	Buy -> Buy	$10.00 -> $8.00	Low	View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 11/28/2023
SWTX SpringWorks Therapeutics	$46.43 +3.8%	11/28/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$52.00 -> $64.00	Low	View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/28/2023
AVXL Anavex Life Sciences	$5.69 +1.8%	11/28/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$54.00	Low	View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/28/2023
ANVS Annovis Bio	$10.82 +9.2%	11/28/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 11/28/2023
GMAB Genmab A/S	$27.79 -0.6%	11/28/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$49.00	Low	View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 11/28/2023
FRLN Freeline Therapeutics	$6.43 +0.5%	11/28/2023	Downgraded by	HC Wainwright	Analyst P. Trucchio	Buy -> Neutral	$15.00 -> $6.50	Low	View details for HC Wainwright rating of Freeline Therapeutics (NASDAQ:FRLN) on 11/28/2023
SLRN Acelyrin	$8.19 +5.1%	11/28/2023	Reiterated by	HC Wainwright	Analyst E. Bodnar	Buy -> Buy	$30.00	Low	View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 11/28/2023
ETNB 89bio	$8.45 +1.3%	11/28/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$35.00	Low	View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 11/28/2023
ARCT Arcturus Therapeutics	$37.91 +1.6%	11/28/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$51.00	Low	View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/28/2023
BRNS Barinthus Biotherapeutics	$2.54 -4.5%	11/28/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$15.00	Low	View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 11/28/2023
KRON Kronos Bio	$1.07 +1.9%	11/27/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Kronos Bio (NASDAQ:KRON) on 11/27/2023
MLTX MoonLake Immunotherapeutics	$61.25 +2.2%	11/27/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$75.00	Low	View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/27/2023
KZR Kezar Life Sciences	$0.95 +2.2%	11/27/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$20.00	Low	View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 11/27/2023
BNTX BioNTech	$94.10 -1.0%	11/27/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$133.00	Low	View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 11/27/2023
CALT Calliditas Therapeutics AB (publ)	$21.50 -0.3%	11/27/2023	Reiterated by	HC Wainwright	Analyst A. He	Buy -> Buy	$50.00	Low	View details for HC Wainwright rating of Calliditas Therapeutics AB (publ) (NASDAQ:CALT) on 11/27/2023
TRDA Entrada Therapeutics	$14.51 +4.8%	11/27/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$25.00 -> $20.00	Low	View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 11/27/2023
GNLX Genelux	$9.37 +11.2%	11/27/2023	Initiated by	HC Wainwright	Analyst E. Bodnar	Buy	$35.00	Low	View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 11/27/2023
NUVB Nuvation Bio	$1.70 +3.7%	11/22/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.50	Low	View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 11/22/2023
BDTX Black Diamond Therapeutics	$4.47 +15.5%	11/22/2023	Reiterated by	HC Wainwright	Analyst R. Burns	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 11/22/2023
EDSA Edesa Biotech	$4.76 -3.6%	11/22/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 11/22/2023
MDWD MediWound	$12.14 -0.2%	11/22/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$26.00	Low	View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 11/22/2023
ARQQ Arqit Quantum	$0.54 +15.0%	11/22/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$4.00 -> $3.00	Low	View details for HC Wainwright rating of Arqit Quantum (NASDAQ:ARQQ) on 11/22/2023
IREN Iris Energy	$5.10 +23.8%	11/22/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$11.00 -> $10.00	Low	View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 11/22/2023
SOL Emeren Group	$1.65 +3.8%	11/22/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$10.00 -> $7.00	Low	View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 11/22/2023
CLDI Calidi Biotherapeutics	$0.59 -6.2%	11/22/2023	Initiated by	HC Wainwright	Analyst R. Burns	Buy	$11.00	N/A	View details for HC Wainwright rating of Calidi Biotherapeutics (NYSEAMERICAN:CLDI) on 11/22/2023
CLDI Calidi Biotherapeutics	$0.60 -5.6%	11/22/2023	Initiated by	HC Wainwright	Analyst R. Burns	Buy	$11.00	N/A	View details for HC Wainwright rating of Calidi Biotherapeutics (NYSEAMERICAN:CLDI) on 11/22/2023
PPBT Purple Biotech	$0.78 -1.3%	11/21/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$9.00 -> $10.00	Low	View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 11/21/2023
ENTA Enanta Pharmaceuticals	$12.36 +0.8%	11/21/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$30.00 -> $28.00	Low	View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 11/21/2023
BLRX BioLineRx	$1.07 -1.8%	11/20/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$21.00	Low	View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 11/20/2023
BLNK Blink Charging	$2.74 +8.3%	11/20/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 11/20/2023
YTRA Yatra Online	$1.62 +0.6%	11/20/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$4.00	Low	View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 11/20/2023
GMAB Genmab A/S	$27.79 -0.6%	11/20/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$49.00	Low	View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 11/20/2023
DRTS Alpha Tau Medical	$3.29 +2.5%	11/20/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$9.00	Low	View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 11/20/2023
KRTX Karuna Therapeutics	$316.12 +0.7%	11/20/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$300.00	Low	View details for HC Wainwright rating of Karuna Therapeutics (NASDAQ:KRTX) on 11/20/2023
SPRB Spruce Biosciences	$3.98 -2.7%	11/20/2023	Reiterated by	HC Wainwright	Analyst B. Pachaiyappan	Buy -> Buy	$10.00	Low	View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 11/20/2023
SWTX SpringWorks Therapeutics	$46.43 +3.8%	11/20/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$58.00 -> $52.00	Low	View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/20/2023
APLM Apollomics	$0.71 +9.2%	11/20/2023	Reiterated by	HC Wainwright	Analyst R. Burns	Buy -> Buy	$17.00	Low	View details for HC Wainwright rating of Apollomics (NASDAQ:APLM) on 11/20/2023
RPTX Repare Therapeutics	$7.97 +1.8%	11/20/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$25.00	Low	View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 11/20/2023
ELBM Electra Battery Materials	$0.53 +23.4%	11/20/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$2.50 -> $1.60	Low	View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 11/20/2023
CVKD Cadrenal Therapeutics	$0.91 -19.5%	11/20/2023	Reiterated by	HC Wainwright	Analyst J. Pantginis	Buy	$3.00	Low	View details for HC Wainwright rating of Cadrenal Therapeutics (NASDAQ:CVKD) on 11/20/2023
HIVE HIVE Digital Technologies	$3.42 +10.0%	11/20/2023	Downgraded by	HC Wainwright	Analyst M. Colonnese	Buy -> Neutral	$7.00 -> $3.50	Low	View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 11/20/2023
DPRO Draganfly	$0.36	11/17/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$2.50	Low	View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 11/17/2023
CYBN Cybin	$0.33 +9.9%	11/17/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$10.00 -> $5.00	N/A	View details for HC Wainwright rating of Cybin (NYSEAMERICAN:CYBN) on 11/17/2023
SLN Silence Therapeutics	$21.20 +0.8%	11/17/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$80.00 -> $75.00	Low	View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 11/17/2023
KALA KALA BIO	$6.94 -0.6%	11/17/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$24.00 -> $22.00	Low	View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 11/17/2023
AKBA Akebia Therapeutics	$1.63 -1.2%	11/17/2023	Target Raised by	HC Wainwright	Analyst E. Arce	Buy -> Buy	$3.75 -> $5.00	Low	View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 11/17/2023
ADMA ADMA Biologics	$5.17 -0.2%	11/17/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$5.00	Low	View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 11/17/2023
GAU Galiano Gold	$0.89	11/16/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$2.10 -> $2.20	N/A	View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 11/16/2023
AREC American Resources	$1.29 -1.5%	11/16/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$3.50 -> $3.25	Low	View details for HC Wainwright rating of American Resources (NASDAQ:AREC) on 11/16/2023
USAS Americas Silver	$0.22	11/16/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$1.50	N/A	View details for HC Wainwright rating of Americas Silver (NYSEAMERICAN:USAS) on 11/16/2023
CLIR ClearSign Technologies	$0.95 -9.6%	11/16/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$6.00	Low	View details for HC Wainwright rating of ClearSign Technologies (NASDAQ:CLIR) on 11/16/2023
GROY Gold Royalty	$1.34 -0.7%	11/16/2023	Target Lowered by	HC Wainwright	-	Buy -> Buy	$8.75 -> $5.50	N/A	View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 11/16/2023
ACLX Arcellx	$61.56 -3.6%	11/15/2023	Target Raised by	HC Wainwright	-	Buy -> Buy	$50.00 -> $60.00	Low	View details for HC Wainwright rating of Arcellx (NASDAQ:ACLX) on 11/15/2023
RMTI Rockwell Medical	$1.23 -1.6%	11/15/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$11.00	Low	View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 11/15/2023
ARCT Arcturus Therapeutics	$37.91 +1.6%	11/15/2023	Reiterated by	HC Wainwright	-	Buy -> Buy	$51.00	Low	View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/15/2023
LLAP Terran Orbital	$0.86 +6.2%	11/15/2023	Target Lowered by	HC Wainwright	Analyst S. Buck	Buy -> Buy	$5.00 -> $3.00	Low	View details for HC Wainwright rating of Terran Orbital (NYSE:LLAP) on 11/15/2023

MarketBeat Community Rating for HC Wainwright

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		22,972 (Vote Outperform)
Underperform Votes:		19,666 (Vote Underperform)
Total Votes:		42,638

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

HC Wainwright Analyst Recommendations & Stock Picks

MarketBeat Community Rating for HC Wainwright

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info